These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. Fu Y; Nathan DM; Li F; Li X; Faustman DL J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790 [TBL] [Abstract][Full Text] [Related]
3. Sex, MHC and complement C4 in autoimmune diseases. Yu CY; Whitacre CC Trends Immunol; 2004 Dec; 25(12):694-9. PubMed ID: 15530841 [TBL] [Abstract][Full Text] [Related]
4. Autoimmunity and suppressor T lymphocytes. Miller KB; Schwartz RS Adv Intern Med; 1982; 27():281-313. PubMed ID: 7041545 [No Abstract] [Full Text] [Related]
5. Immunoglobulin allotypes and RFLPs in disease association. Propert D Exp Clin Immunogenet; 1995; 12(3):198-205. PubMed ID: 8534506 [TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of HLA class II and some autoimmune diseases. Lepage V; Lamm LU; Charron D Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813 [No Abstract] [Full Text] [Related]
9. Immunologic and genetic factors in autoimmune diseases. Shoenfeld Y; Schwartz RS N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779 [No Abstract] [Full Text] [Related]
10. The major histocompatibility complex and autoimmunity. Chaplin DD; Kemp ME Year Immunol; 1988; 3():179-98. PubMed ID: 3327310 [TBL] [Abstract][Full Text] [Related]
12. On the future of HLA. Thorsby E Tissue Antigens; 2011 Oct; 78(4):229-40. PubMed ID: 21929571 [TBL] [Abstract][Full Text] [Related]
13. [HLA class I and II antigens and diffuse toxic goiter]. Kalinin AP; Kamynina TS; Zaretskaia IuM; Abramov VIu; Klinova EG; Karachintsev VI Ter Arkh; 1993; 65(3):81-5. PubMed ID: 8059394 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and systemic lupus erythematosus. Occurrence in two generations of the same family. Sloan JB; Berk MA; Gebel HM; Fretzin DF Arch Intern Med; 1987 Jul; 147(7):1317-20. PubMed ID: 3496864 [TBL] [Abstract][Full Text] [Related]
15. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families. Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512 [TBL] [Abstract][Full Text] [Related]
16. HLA typing in a large family with multiple cases of different autoimmune diseases. Sels F; Westhovens R; Emonds MP; Vandermeulen E; Dequeker J J Rheumatol; 1997 May; 24(5):856-9. PubMed ID: 9150072 [TBL] [Abstract][Full Text] [Related]
17. Autoimmunity of thyroid disease. With emphasis on Graves' disease. van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065 [No Abstract] [Full Text] [Related]
18. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus. Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231 [TBL] [Abstract][Full Text] [Related]
19. HSP70-1 promoter region polymorphism tested in three autoimmune diseases. Cascino I; Galeazzi M; Salvetti M; Ristori G; Morozzi G; Richiardi PM; Tosi R Immunogenetics; 1994; 39(4):291-3. PubMed ID: 8119737 [No Abstract] [Full Text] [Related]
20. [Association between HLA and disease. Current status and perspectives]. Corrales Padilla H; Corrales Alvarez H; Carias S Med Cutan Ibero Lat Am; 1986; 14(1):27-41. PubMed ID: 3526034 [No Abstract] [Full Text] [Related] [Next] [New Search]